EGR1 and hepatocellular carcinoma: In order to explore the potential impact of EGR1 downregulation on the efficacy of sorafenib in HCC, we utilized the genomics of drug sensitivity in cancer (GDSC) database to predict IC50 values of sorafenib based on EGR1 expression.